NCT00660140 Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00653978 Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures Status UNKNOWN Phase PHASE3
NCT00630890 Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) Status TERMINATED Phase PHASE1
NCT00604266 Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study Status WITHDRAWN Phase N/A
NCT00540735 Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas Status TERMINATED Phase PHASE3
NCT00465023 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases Status COMPLETED Phase NA
NCT00414843 Storage of Bile From Routine Procedures to Study Risk Factors Status TERMINATED Phase N/A
NCT00350961 Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00320918 Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib Status TERMINATED Phase N/A
NCT00301379 Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients Status TERMINATED Phase N/A
NCT00290316 Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver Status UNKNOWN Phase PHASE2
NCT00230347 Evaluation of Stereotactic Radiosurgery For Liver Malignancies Status COMPLETED Phase PHASE1
NCT00168987 Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors Status COMPLETED Phase PHASE4
NCT00160836 Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter Status UNKNOWN Phase PHASE1
NCT00041808 Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver Status COMPLETED Phase PHASE1/PHASE2